title: OKT3/antithymocyte globulin immunoprophylaxis in the prevention of recurrence of acute vanishing bile duct syndrome in retransplanted patients.
authors.affiliation: Department of General and Digestive Surgery, University Hospital 12 de Octubre, Madrid, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Gómez
authors.forename: E
authors.initials: E
authors.lastname: Moreno
authors.forename: F
authors.initials: F
authors.lastname: Colina
authors.forename: I
authors.initials: I
authors.lastname: Gonzalez
authors.forename: C
authors.initials: C
authors.lastname: Loinaz
authors.forename: I
authors.initials: I
authors.lastname: Garcia
authors.forename: I
authors.initials: I
authors.lastname: Luque
authors.forename: C
authors.initials: C
authors.lastname: Lumbreras
authors.forename: V
authors.initials: V
authors.lastname: Vega
authors.forename: C
authors.initials: C
authors.lastname: Moreno
mesh_terms: D000208:Acute Disease; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001649:Bile Duct Diseases / Q000517:prevention & control*; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D015994:Incidence; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000453:epidemiology; D012008:Recurrence; D012086:Reoperation; D013577:Syndrome; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D008775:Methylprednisolone